Search results for: 'thin posit through with propen are label'

One kit of amino acids mixture allows the use of 2 starter CFPS kits or 1 large scale CFPS kit

• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 k Da
• Labeling: ¹³C, ¹⁵N, D

• 10 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N, D

• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N, D

• 5 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N, D

• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

• Full Length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

• Full Length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0
• Stable for more than 2 years at 4°C

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0
• Stable for more than 2 years at 4°C

• Maltose Binding Protein (Recombinant MBP)
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Protein conc.: 1 mM
• Labeling: ¹³C, ¹⁵N, D
• 20 mM Phosphate, pH: 7.2, Maltotriose: 3 mM, NaN₃: 3 mM, Pefabloc: 50 µM

• Maltose Binding Protein (Recombinant MBP)
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Protein conc.: 1 mM
• Labeling: ¹³C, ¹⁵N, D
• 20 mM Phosphate, pH: 7.2, Maltotriose: 3 mM, NaN₃: 3 mM, Pefabloc: 50 µM

• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded (Ca and Ln loaded also available on request)
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D
• Concentration: 1 mM
• H₂O/D₂O: 90/10, pH: 6.0
• Protein supplied in a 3 mm NMR tube sealed under Argon

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

10 mg

10 mg

10 mg

10 mg

10 mg

10 mg

10 mg

10 mg

10 mg

10 mg

10 mg

10 mg

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

• 1 g
• ¹³C, ¹⁵N, D labeled
• Powder Growth Media

• 10 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: ¹³C, ¹⁵N, D
• Crystallized

• 20 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: ¹³C, ¹⁵N, D
• Crystallized

• 5 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: ¹³C, ¹⁵N, D
• Crystallized

• 50 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: ¹³C, ¹⁵N, D
• Crystallized